Skip to main content

TAU Inaugurates Shmunis School of Biomedicine and Cancer Research

Written on |
School is funded with a generous gift from the Shmunis family for research and improved treatments for cancer, COVID-19, and other diseases Tel Aviv University inaugurated the Shmunis School of Biomedicine and Cancer Research, in the presence of Israel’s Minister of Science and Technology Izhar Shay and benefactors Vlad and Sana Shmunis, online, via RingCentral. The new School, part of the George S. Wise Faculty of Life Sciences will enable a leap in biomedical research.  The School’s 300 researchers, students and staff in the fields of cancer research, cancer immunity, bioinformatics, microbiology, biotechnology, and more, will work to identify mechanisms that drive cancer and other diseases. Moreover, they will develop new pharmaceuticals and improve patients’ quality of life. This will be achieved through multidisciplinary collaborations and novel research approaches, such as single cell sequencing and bioinformatics. Vlad and Sana Shmunis expressed hope that their gift will help strengthen Israel’s standing as a global leader in cancer and molecular biomedical research. “In supporting TAU, we firmly believe that we have found an ideal partner to move the needle towards curing cancer and other terrible diseases,” said Vlad Shmunis, Chief Executive Officer and Founder of RingCentral, Inc. “Cancer is a disease that has unfortunately touched our family and far too many other families.  We hope that our gift to TAU will … improve the lives of people in Israel and around the world.” The new partnership will enable the University to recruit the finest researchers and award the annual Shmunis Fellowships to exceptional PhD students. The School will also collaborate with leading academic institutions and host Shmunis Visiting Scholars and international conferences.

Recent Shmunis School achievements:

  • The Gershoni Lab was awarded a US patent for a novel vaccine against the coronavirus
  • The Stern Lab‘s genetic sequencing of the coronavirus tracked the spread of COVID-19 in Israel
  • The Ehrlic Lab is developing virus-based immunotherapies for cancer ​
  • The Lederkremer Lab developed a therapeutic approach for Huntington’s disease, for which no treatment exists
“I am grateful to the Shmunis family for their important and generous gift,” said Prof. Ariel Porat, President of Tel Aviv University. “Meeting high standards of other renowned centers for cancer research around the globe, the School will be a hub for the brightest Israeli and international researchers to join as faculty.” This is the Shmunis family’s second major donation to the University. They founded the Shmunis Family Anthropology Institute in 2018 dedicated to the study of the ancient past. The Institute conducts numerous cutting-edge research projects in anthropology and archaeology on campus, helping to shed light on the origins of humankind. Featured image: Prof. Ariel Porat, TAU President, and Prof. Tal Pupko, head of the Shmunis School, at the Shmunis School Inauguration Ceremony. Photo: Chen Galili.

Related posts

Is Treatment for Genetic Autism on the Horizon?

25 November 2024

Nasal Spray Revolutionizes COVID Protection

21 November 2024

Is There a Way to Stop Parkinson’s Disease at Its Source?

14 November 2024

How Does the Brain Keep Calm?

14 November 2024

Hyperbaric Oxygen Therapy: A Promising Treatment for PTSD Symptoms

11 November 2024

TAU Breakthrough Reveals Mechanism That Eliminates Tumors

3 November 2024

Could Cancer Vulnerabilities Be Hidden in Chromosome Changes?

23 September 2024

Spotting Parkinson’s Early: A New TAU Breakthrough

17 September 2024

How Can We See Through Closed Eyes?

16 September 2024

Can Parkinson’s Treatment be Enhanced by AI Tech?

1 September 2024

Want to Fall in Love? Step Outside in The Sun

19 August 2024

Can Smartwatches Prevent Pandemic Outbreaks?

7 August 2024

How Close Are We to Thought-Based Communication?

22 July 2024

Will Wearable Tech Transform Neurological Diagnosis?

21 July 2024

Will Existing Drugs Stop Cancer’s Bone Spread?

19 May 2024

Heart Disease’s Cancer Link Unveiled

14 April 2024

Victoria

Tok Corporate Centre, Level 1,
459 Toorak Road, Toorak VIC 3142
Phone: +61 3 9296 2065
Email: [email protected]

New South Wales

Level 22, Westfield Tower 2, 101 Grafton Street, Bondi Junction NSW 2022
Phone: +61 418 465 556
Email: [email protected]

Western Australia

P O Box 36, Claremont,
WA  6010
Phone: :+61 411 223 550
Email: [email protected]